“Super Responder” of Percutaneous Bicaval Valve Implantation for Severe Tricuspid Regurgitation: A Case Report
Keywords:
Bicaval Valve, TricValve, Implantation, Tricuspid Regurgitation, EchocardiographicAbstract
Tricuspid Regurgitation (TR) surgical treatment is associated to high operative mortality, suboptimal long-term survival, and frequent TR recurrence after repair, especially in the elderly. This case report highlights our early experience of TricValve implantation in Indonesia, conducted on a 72-year-old male patient with severe tricuspid regurgitation and advanced right ventricular dysfunction. In this context, the TricValve system offers a promising, less invasive alternative. Despite previous pharmacological management, our patient had been readmitted multiple times due to refractory right heart failure. One month post-TricValve implantation, he showed significant symptomatic relief and stable cardiac function as evidenced by echocardiographic measurements. This case underscores the potential utility of the TricValve system in providing an effective, lower-risk treatment option for patients not suited for traditional surgical intervention.References
Mangieri A, Montalto C, Pagnesi M, et al. Mechanism and implications of the tricuspid regurgitation. Circ Cardiovasc Interv [Internet]. 2017 [cited 2023 Sep 5]; Available from: https://www.ahajournals.org/doi/abs/10.1161/CIRCINTERVENTIONS.117.005043
Badano LP, Muraru D, Enriquez-Sarano M. Assessment of functional tricuspid regurgitation. Eur Heart J. 2013 Jul;34(25):1875–85.
Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004 Feb 4;43(3):405–9.
Taramasso M, Vanermen H, Maisano F, Guidotti A, La Canna G, Alfieri O. The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol. 2012 Feb 21;59(8):703–10.
Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. 2017 Dec 19;70(24):2953–60.
Abdul-Jawad Altisent O, Benetis R, Rumbinaite E, et al. Caval valve implantation (CAVI): An emerging therapy for treating severe tricuspid regurgitation. J Clin Med Res [Internet]. 2021 Oct 7;10(19). Available from: http://dx.doi.org/10.3390/jcm10194601
Dreyfus J, Flagiello M, Bazire B, et al. Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes. Eur Heart J. 2020 Sep 25;41(45):4304–17.
Mulla S, Asuka E, Bora V, Siddiqui WJ. Tricuspid regurgitation. StatPearls Publishing; 2022.
Baratto C, Caravita S, Corbetta G, et al. Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction. Front Cardiovasc Med. 2023 Mar 1;10:1061118.
Henning RJ. Tricuspid valve regurgitation: current diagnosis and treatment. Am J Cardiovasc Dis. 2022 Feb 15;12(1):1–18.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e35–71.
Besler’ [’christian, Seeburger’ ’joerg, Thiele’ ’holger, Lurz’] ’philipp. Treatment options for severe functional tricuspid regurgitation: indications, techniques and current challenges [Internet]. [cited 2023 Sep 11]. Available from: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-16/Treatment-options-for-severe-functional-tricuspid-regurgitation-indications-techniques-and-current-challenges
Kültürsay B, Bingöl G, Güven B, Yıldız A, Ökçün B. TricValve pop-out: Management of transcatheter caval valve migration. Anatol J Cardiol. 2022 May;26(5):414–8.
Estévez-Loureiro R, Sánchez-Recalde A, Amat-Santos IJ, et al. 6-month outcomes of the TricValve system in patients with tricuspid regurgitation: The TRICUS EURO study. JACC Cardiovasc Interv. 2022 Jul 11;15(13):1366–77.
Case Medical Research. TRICUS STUDY euro - safety and efficacy of the TricValve® device. Case Medical Research [Internet]. 2019 Oct 28; Available from: https://ichgcp.net/clinical-trials-registry/NCT03723239
Papazoglou AS, Moysidis DV, Kartas A, et al. Oral anticoagulation challenges and therapeutic dilemmas in the very elderly: to treat and how to treat octogenarians and nonagenarians? Pol Arch Intern Med. 2023; 133: 16508. doi:10.20452/pamw.16508
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
